Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Fifer

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
BMJ (Clinical Research Ed.)|February 4, 2017
First line dual therapy for gonorrhoea to limit the spread of antimicrobial resistanceHamish Mohammed, Bersabeh Sile, Martina Furegato, et al.
Sexually Transmitted Infections|June 5, 2021
Detection of markers predictive of macrolide and fluoroquinolone resistance in <i>Mycoplasma genitalium</i> from patients attending sexual health servicesMichaela Joanne Day, Michelle Jayne Cole, Helen Fifer, et al.
Sexually Transmitted Infections|March 29, 2025
Updates to the notifiable disease legislation in England to facilitate surveillance of selected STI-related complicationsHamish Mohammed, Kate Folkard, Matt Phillips, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 14, 2018
Persistence of an outbreak of gonorrhoea with high-level resistance to azithromycin in England, November 2014‒May 2018Christa Smolarchuk, Adrian Wensley, Simon Padfield, et al.
The New England Journal of Medicine|June 23, 2016
Failure of Dual Antimicrobial Therapy in Treatment of GonorrheaHelen Fifer, Usha Natarajan, Lucy Jones, et al.
Emerging Infectious Diseases|January 3, 2024
Rebound of Gonorrhea after Lifting of COVID-19 Preventive Measures, EnglandHolly Fountain, Stephanie J Migchelsen, Hannah Charles, et al.
Journal of Medical Microbiology|October 28, 2025
A testing time for gradient strips: an evaluation of ETEST for the antimicrobial susceptibility testing of <i>Neisseria gonorrhoeae</i>Rachel Pitt-Kendall, Jack Minshull, Sandhya Vivekanand, et al.
The Journal of Antimicrobial Chemotherapy|December 8, 2021
Use of genomics to investigate Neisseria gonorrhoeae antimicrobial susceptibility testing discrepanciesHelen Fifer, Ulf Schaefer, Rachel Pitt, et al.
BMJ Open|June 16, 2017
Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of <i>Neisseria gonorrhoeae</i>: a modelling studyKaty Me Turner, Hannah Christensen, Elisabeth J Adams, et al.
The Journal of Infection|August 9, 2025
The United Kingdom meningococcal vaccine (4CMenB) programme against gonorrhoea: A review of the evidence and knowledge gapsShamez N Ladhani, Sema Mandal, Hamish Mohammed, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
BMJ (Clinical Research Ed.)|February 4, 2017
First line dual therapy for gonorrhoea to limit the spread of antimicrobial resistanceHamish Mohammed, Bersabeh Sile, Martina Furegato, et al.
Sexually Transmitted Infections|June 5, 2021
Detection of markers predictive of macrolide and fluoroquinolone resistance in <i>Mycoplasma genitalium</i> from patients attending sexual health servicesMichaela Joanne Day, Michelle Jayne Cole, Helen Fifer, et al.
Sexually Transmitted Infections|March 29, 2025
Updates to the notifiable disease legislation in England to facilitate surveillance of selected STI-related complicationsHamish Mohammed, Kate Folkard, Matt Phillips, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 14, 2018
Persistence of an outbreak of gonorrhoea with high-level resistance to azithromycin in England, November 2014‒May 2018Christa Smolarchuk, Adrian Wensley, Simon Padfield, et al.
The New England Journal of Medicine|June 23, 2016
Failure of Dual Antimicrobial Therapy in Treatment of GonorrheaHelen Fifer, Usha Natarajan, Lucy Jones, et al.
Emerging Infectious Diseases|January 3, 2024
Rebound of Gonorrhea after Lifting of COVID-19 Preventive Measures, EnglandHolly Fountain, Stephanie J Migchelsen, Hannah Charles, et al.
Journal of Medical Microbiology|October 28, 2025
A testing time for gradient strips: an evaluation of ETEST for the antimicrobial susceptibility testing of <i>Neisseria gonorrhoeae</i>Rachel Pitt-Kendall, Jack Minshull, Sandhya Vivekanand, et al.
The Journal of Antimicrobial Chemotherapy|December 8, 2021
Use of genomics to investigate Neisseria gonorrhoeae antimicrobial susceptibility testing discrepanciesHelen Fifer, Ulf Schaefer, Rachel Pitt, et al.
BMJ Open|June 16, 2017
Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of <i>Neisseria gonorrhoeae</i>: a modelling studyKaty Me Turner, Hannah Christensen, Elisabeth J Adams, et al.
The Journal of Infection|August 9, 2025
The United Kingdom meningococcal vaccine (4CMenB) programme against gonorrhoea: A review of the evidence and knowledge gapsShamez N Ladhani, Sema Mandal, Hamish Mohammed, et al.
Pageof 10